441 related articles for article (PubMed ID: 27732798)
1. Targeted Protein Degradation by Small Molecules.
Bondeson DP; Crews CM
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():107-123. PubMed ID: 27732798
[TBL] [Abstract][Full Text] [Related]
2. Design and pharmaceutical applications of proteolysis-targeting chimeric molecules.
Liang Y; Nandakumar KS; Cheng K
Biochem Pharmacol; 2020 Dec; 182():114211. PubMed ID: 32866456
[TBL] [Abstract][Full Text] [Related]
3. Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.
Xi M; Chen Y; Yang H; Xu H; Du K; Wu C; Xu Y; Deng L; Luo X; Yu L; Wu Y; Gao X; Cai T; Chen B; Shen R; Sun H
Eur J Med Chem; 2019 Jul; 174():159-180. PubMed ID: 31035238
[TBL] [Abstract][Full Text] [Related]
4. Small-Molecule PROTACS: New Approaches to Protein Degradation.
Toure M; Crews CM
Angew Chem Int Ed Engl; 2016 Feb; 55(6):1966-73. PubMed ID: 26756721
[TBL] [Abstract][Full Text] [Related]
5. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins.
Buckley DL; Raina K; Darricarrere N; Hines J; Gustafson JL; Smith IE; Miah AH; Harling JD; Crews CM
ACS Chem Biol; 2015 Aug; 10(8):1831-7. PubMed ID: 26070106
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs.
An S; Fu L
EBioMedicine; 2018 Oct; 36():553-562. PubMed ID: 30224312
[TBL] [Abstract][Full Text] [Related]
7. Targeted protein degradation by PROTACs.
Neklesa TK; Winkler JD; Crews CM
Pharmacol Ther; 2017 Jun; 174():138-144. PubMed ID: 28223226
[TBL] [Abstract][Full Text] [Related]
8. Targeted protein knockdown using small molecule degraders.
Raina K; Crews CM
Curr Opin Chem Biol; 2017 Aug; 39():46-53. PubMed ID: 28605671
[TBL] [Abstract][Full Text] [Related]
9. Protein degradation: a validated therapeutic strategy with exciting prospects.
Lebraud H; Heightman TD
Essays Biochem; 2017 Nov; 61(5):517-527. PubMed ID: 28970340
[TBL] [Abstract][Full Text] [Related]
10. Targeted protein degradation: A promise for undruggable proteins.
Samarasinghe KTG; Crews CM
Cell Chem Biol; 2021 Jul; 28(7):934-951. PubMed ID: 34004187
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs).
Tomaselli D; Mautone N; Mai A; Rotili D
Eur J Med Chem; 2020 Dec; 207():112750. PubMed ID: 32871345
[TBL] [Abstract][Full Text] [Related]
12. Targeted Protein Degradation: from Chemical Biology to Drug Discovery.
Cromm PM; Crews CM
Cell Chem Biol; 2017 Sep; 24(9):1181-1190. PubMed ID: 28648379
[TBL] [Abstract][Full Text] [Related]
13. Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules.
Okuhira K; Shoda T; Omura R; Ohoka N; Hattori T; Shibata N; Demizu Y; Sugihara R; Ichino A; Kawahara H; Itoh Y; Ishikawa M; Hashimoto Y; Kurihara M; Itoh S; Saito H; Naito M
Mol Pharmacol; 2017 Mar; 91(3):159-166. PubMed ID: 27965304
[TBL] [Abstract][Full Text] [Related]
14. Optical control of targeted protein degradation.
Reynders M; Trauner D
Cell Chem Biol; 2021 Jul; 28(7):969-986. PubMed ID: 34115971
[TBL] [Abstract][Full Text] [Related]
15. Development of targeted protein degradation therapeutics.
Chamberlain PP; Hamann LG
Nat Chem Biol; 2019 Oct; 15(10):937-944. PubMed ID: 31527835
[TBL] [Abstract][Full Text] [Related]
16. Controlling PROTACs with Light.
Verma S; Manna D
ChemMedChem; 2020 Jul; 15(14):1258-1261. PubMed ID: 32558301
[TBL] [Abstract][Full Text] [Related]
17. Targeting oncoproteins for degradation by small molecules in myeloid leukemia.
Lei H; Wang W; Wu Y
Leuk Lymphoma; 2018 Oct; 59(10):2297-2304. PubMed ID: 29198160
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Modulation of Protein Homeostasis.
Burslem GM; Crews CM
Chem Rev; 2017 Sep; 117(17):11269-11301. PubMed ID: 28777566
[TBL] [Abstract][Full Text] [Related]
19. Protein degradation: Prime time for PROTACs.
Deshaies RJ
Nat Chem Biol; 2015 Sep; 11(9):634-5. PubMed ID: 26284668
[No Abstract] [Full Text] [Related]
20. RGD-mediated delivery of small-molecule drugs.
Katsamakas S; Chatzisideri T; Thysiadis S; Sarli V
Future Med Chem; 2017 Apr; 9(6):579-604. PubMed ID: 28394627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
